Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide use in pediatric patients.

Olga Bessmertny1, Trinh Pham

  • 1Pediatric/Hematology/Oncology/Bone Marrow Transplantation, Columbia Presbyterian Medical Center, New York, NY, USA.

The Annals of Pharmacotherapy
|March 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

The Morphologic and Molecular Heterogeneity of Fumarate Hydratase-deficient Leiomyomas: Integrative Molecular Profiling of Uterine Smooth Muscle Tumors With Histologic Feature Correlation.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2025
Same author

Comparative analysis of the postadmission and antemortem oropharyngeal and rectal swab microbiota of ICU patients.

Scientific reports·2024
Same author

Endothelial knockdown of the tumor suppressor, <i>WWOX</i>, increases inflammation in ventilator-induced lung injury.

American journal of physiology. Lung cellular and molecular physiology·2024
Same author

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy.

The journal of allergy and clinical immunology. Global·2023
Same author

Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.

European urology oncology·2021

Thalidomide shows effectiveness in chronic graft-versus-host disease (GVHD) and aphthous ulcers in HIV-infected children. Its use is recommended as a last resort for pediatric patients when other treatments fail.

Area of Science:

  • Pediatric pharmacology
  • Immunology
  • Dermatology

Background:

  • Thalidomide, a teratogenic drug, has demonstrated immunomodulatory properties.
  • Its use in pediatric populations requires careful consideration due to potential side effects.

Purpose of the Study:

  • To review the existing literature on thalidomide's efficacy and safety in pediatric patients.
  • To identify specific conditions where thalidomide may be beneficial in children.

Main Methods:

  • A comprehensive literature search was conducted using MEDLINE (1966-February 2001).
  • Keywords included thalidomide, child, graft-versus-host disease, cancer, HIV, Crohn's disease, Behçet's disease, and lupus erythematosus.
  • References from identified articles were also reviewed.

Related Experiment Videos

Main Results:

  • Thalidomide appears effective for chronic graft-versus-host disease (GVHD) and aphthous ulcers in HIV-infected children.
  • Limited evidence suggests efficacy for cutaneous manifestations of Behçet's disease, Crohn's disease, and lupus in children, with high recurrence rates upon discontinuation.
  • Efficacy in acute GVHD and cancer was not clearly established.

Conclusions:

  • Thalidomide should be considered a last-resort treatment option for pediatric patients.
  • Preferential use in male or prepubescent female patients is suggested.
  • Careful risk-benefit assessment is crucial due to potential teratogenicity and disease recurrence.